Inflammatory molecules
|
Cytokines |
IL-4, IL-13 |
2–6 ng mL−1
|
48 h |
Neisseria, E.coli, zymosan |
n/a |
100 per cell |
2 h |
Mouse peritoneal macrophages |
IL-4 and IL-13 ↓ uptake of bacteria and zymosan via IL-4/IL-13 receptors |
362
|
IL-4 |
10 ng mL−1
|
48 h |
YG™ |
1 μm |
108 mL−1
|
0.5 h |
Primary BM mononuclear cells |
IL-4 ↓ phagocytosis of YG beads in macrophages |
364
|
20 ng mL−1
|
48 h |
B-lymphoma cells |
n/a |
106 mL−1
|
n/a |
Human macrophages |
IL-4 ↓ phagocytosis of rituximab opsonized lymphoma cells by macrophages |
365
|
|
Co-exposure with different nanoparticles
|
Nano-particles |
SiO2
|
10–250 μg mL−1
|
24–72 h |
Fe3O4
|
20–30 nm |
10–250 μg mL−1
|
24–72 h |
A549 |
Effect on NPs uptake unknown; ↓ ROS and toxicity in co-exposure |
367
|
|
Surface modification
|
Proteins |
HSA |
100 μM |
n/a |
DHLA-QDs |
5 nm |
10 nM |
2 h |
HeLa |
HSA ↓ DHLA-QDs endocytosis |
418
|
FBS |
0, 10, 55% |
n/a |
SiO2–PEG–Tf |
50 nm |
50 μg mL−1
|
1–8 h |
A549 |
FBS proteins ↓ TfR targeting for Tf-conjugated NPs |
272
|
Polyethylene-glycol |
Amino-PEG |
10.000 g mol−1
|
n/a |
PS |
30, 50, 100 nm |
1013–1015 mL−1
|
8–24 h |
Primary BMDM |
Amino-PEG coating ↓ PS NPs uptake |
292
|
PEG |
n/a |
n/a |
FePt, Fe3O4
|
4–11 nm |
5–10 nM |
12 h |
NIH/3T3 |
PEGylation ↓ uptake of the NPs for 10% |
375
|
Thiolated-PEG |
50 PEG per nm2 Au |
n/a |
Au |
15 nm |
20 nM |
1–24 h |
A549 |
Thiolated-PEG ↓ uptake of Au NPs |
128
|
Surface markers |
CD47 |
n/a |
n/a |
PS |
30, 50, 100 nm |
1013–1015 mL−1
|
8–24 h |
BMDM |
↓ phagocytosis of PS NPs, coated with CD47 |
292
|
21 μm−2 bead |
n/a |
Streptavidin–PS |
100, 160, 1100, 3500 nm |
n/a |
3/4 h |
THP-1 |
CD47 ↓ phagocytosis of streptavidin–PS by signalling through the phagocyte receptor SIRPα |
398
|
|
Bio-inspired molecules
|
Bacterial proteins |
Yersinia (Yop) |
400 μg mL−1
|
n/a |
n/a |
n/a |
n/a |
n/a |
HeLa |
YopE ↓ internalization of bacteria by ↓ PI3K/AKT pathway |
419
|
n/a |
1 h |
n/a |
n/a |
n/a |
n/a |
Murine BMDC |
YopE, YopH and YopT ↓ uptake of bacteria by actin fibers destruction |
408
|
n/a |
1 h |
n/a |
n/a |
n/a |
n/a |
J774A.1 |
YopH ↓ internalization of bacteria via ↓ PI3K/AKT pathway |
407
|
Streptococcus (Sic) |
10 μg mL−1
|
1 h |
n/a |
n/a |
n/a |
n/a |
PMN |
Sic ↓ phagocytosis of bacteria |
409
|
Viral proteins |
Herpes virus (K14) |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
MDM |
K14 ↓ macrophage activation by interacting with human CD200R; unknown effect on uptake |
420
|
Fatty acids |
Oleic, stearic, α-linoleic |
500 μM |
n/a |
ZnO |
22 nm |
4 μg mL−1
|
6 h |
THP-1 |
FFA ↓ the NPs uptake and alter NPs–cell interactions |
411
|
|
Others
|
Chloroquine |
n/a |
20–400 μM |
n/a |
Albumin, lyposome, PS, silicon |
14–264 nm |
Albumin: 20 μg mL−1; liposomes: 200–400 μM; PS: 3 × 109 mL−1; silicon: 6 × 107 mL−1
|
3–6 h |
J774A.1, RAW264.7, Kupffer cells MDA-MB-231, MIA PaCa-2, H358 lung cancer cells |
Chloroquine ↓ NPs uptake via clathrin-mediated endocytosis by ↓ PICALM expression |
179
|